“…So far, it has been proposed that the 17q12 deletion syndrome includes different renal diseases; endocrine, exocrine, and structural pancreatic abnormalities; liver cysts; elevation of liver enzymes; learning disability; macrocephaly; growth restriction; epilepsy; autism; structural brain abnormalities; behavioral abnormalities; schizophrenia; facial dysmorphism; neonatal transient hypercalcemia; congenital diaphragmatic hernia; duodenal atresia; prune belly syndrome (OMIM #100100); Müllerian aplasia; obesity; and joint laxity [Bellanne‐Chantelot et al, ; Mefford et al, ; Bernardini et al, ; Raile et al, ; Haeri et al, ; Moreno‐De‐Luca et al, ; Nagamani et al, ; Loirat et al, ; Dixit et al, ; Hendrix et al, ; Hinkes et al, ; Palumbo et al, ; Quintero‐Rivera et al, ; Goumy et al, ]. The 17q12 duplication syndrome has mainly been proposed to include autism, behavioral abnormalities, structural brain abnormalities, learning disability, epilepsy, schizophrenia, facial dysmorphism, renal disease, joint laxity, esophageal atresia, anal atresia, and endocrine abnormalities [Mefford et al, ; Nagamani et al, ; Faguer et al, ; Brandt et al, ; Bierhals et al, ; Hardies et al, ; Smigiel et al, ; Szatkiewicz et al, ; Mitchell et al, ].…”